Matisse Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$914K Hold
2,350
0.43% 76
2025
Q1
$1.02M Hold
2,350
0.54% 61
2024
Q4
$867K Sell
2,350
-200
-8% -$73.8K 0.44% 74
2024
Q3
$1.33M Hold
2,550
0.64% 50
2024
Q2
$1.38M Sell
2,550
-137
-5% -$74.2K 0.68% 50
2024
Q1
$1.39M Sell
2,687
-200
-7% -$104K 0.67% 46
2023
Q4
$1.36M Buy
2,887
+1,400
+94% +$660K 0.73% 39
2023
Q3
$647K Sell
1,487
-2,000
-57% -$871K 0.46% 84
2023
Q2
$1.55M Hold
3,487
0.96% 19
2023
Q1
$1.6M Hold
3,487
1.03% 16
2022
Q4
$1.79M Buy
+3,487
New +$1.79M 1.59% 10
2022
Q3
Sell
-3,622
Closed -$1.75M 96
2022
Q2
$1.75M Hold
3,622
1.66% 13
2022
Q1
$1.78M Buy
3,622
+350
+11% +$172K 1.64% 16
2021
Q4
$1.52M Sell
3,272
-1,000
-23% -$464K 1.05% 24
2021
Q3
$1.59M Hold
4,272
0.59% 45
2021
Q2
$1.63M Buy
4,272
+2,000
+88% +$764K 0.52% 53
2021
Q1
$815K Hold
2,272
0.23% 81
2020
Q4
$729K Hold
2,272
0.23% 87
2020
Q3
$610K Hold
2,272
0.24% 73
2020
Q2
$597K Hold
2,272
0.2% 90
2020
Q1
$516K Buy
2,272
+825
+57% +$187K 0.2% 99
2019
Q4
$437K Hold
1,447
0.31% 66
2019
Q3
$347K Hold
1,447
0.43% 59
2019
Q2
$408K Hold
1,447
0.52% 47
2019
Q1
$415K Sell
1,447
-87
-6% -$25K 0.5% 52
2018
Q4
$403K Hold
1,534
0.51% 48
2018
Q3
$420K Buy
1,534
+85
+6% +$23.3K 0.38% 68
2018
Q2
$345K Hold
1,449
0.27% 80
2018
Q1
$318K Hold
1,449
0.19% 91
2017
Q4
$326K Hold
1,449
0.15% 100
2017
Q3
$275K Hold
1,449
0.13% 97
2017
Q2
$273K Buy
+1,449
New +$273K 0.14% 91